← Back to Search

Behavioral Intervention

Pain Management Interventions for Cancer

N/A
Recruiting
Led By Andrea L. Cheville, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site
Pain that developed (onset) or significantly worsened since cancer diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial researches new pain management interventions to help rural and Hispanic cancer survivors with pain.

Who is the study for?
This trial is for adults over 18 with pain from cancer like leukemia, lymphoma, or myeloma. They must have a pain score of at least 5 out of 10 and be treated at a participating Mayo site. It's not for those with severe depression (PHQ score ≥10), in hospice care, or with less than a year to live.Check my eligibility
What is being tested?
The study tests various pain management methods such as massage, acupuncture, spiritual care, cognitive therapy, and more on rural dwelling and Hispanic cancer survivors to improve their quality of life and manage cancer-related pain effectively.See study design
What are the potential side effects?
While the trial focuses on non-drug therapies which typically have minimal side effects compared to medications, some participants may experience discomfort or mild reactions related to specific interventions like acupuncture or massage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a cancer diagnosis and visit a Mayo clinic for it.
Select...
My pain started or got worse after my cancer diagnosis.
Select...
My condition is a type of blood cancer such as lymphoma, myeloma, or chronic leukemia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participant response rates
Usability and acceptability of final visit - cancer pain management component
Usability and acceptability of follow-up visit - barriers to pain care
+19 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Group I (Pain management)Experimental Treatment15 Interventions
See detailed description.
Group II: Group II (Interview)Active Control1 Intervention
ASCENT study interventionists complete an interview on study.
Group III: Group III (Focus group)Active Control1 Intervention
Medical oncology providers participate in a focus group on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spiritual Therapy
2022
N/A
~30
Patient Navigation
2017
Completed Phase 2
~38910
Pain Therapy
2015
Completed Phase 3
~190
Acupuncture Therapy
2018
Completed Phase 2
~130
Cognitive Behavior Therapy
2010
Completed Phase 3
~2630
Massage Therapy
2012
Completed Phase 2
~840

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,216 Previous Clinical Trials
3,767,348 Total Patients Enrolled
76 Trials studying Multiple Myeloma
9,571 Patients Enrolled for Multiple Myeloma
Andrea L. Cheville, M.D.Principal InvestigatorMayo Clinic in Rochester
1 Previous Clinical Trials
660 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for participant recruitment in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this clinical trial is presently seeking participants; it was first published on May 25th 2023 and last edited on September 29th 2023. The research requires 140 people to be recruited from two separate medical centres."

Answered by AI

Are participants being enrolled at this time in the experiment?

"Affirmative. Records on clinicaltrials.gov indicate that this medical experiment commenced recruiting on May 25th 2023 and is currently ongoing, with the most recent update occurring September 29th 2023. 140 patients are required from 2 different sites for participation in the trial."

Answered by AI
~70 spots leftby May 2025